PUBLISHER: Grand View Research | PRODUCT CODE: 2188736
PUBLISHER: Grand View Research | PRODUCT CODE: 2188736
The global cell line development services market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.4 billion in 2026 to USD 2.9 billion by 2033, at a CAGR of 10.9% from 2026 to 2033. North America dominated the market, accounting for the revenue share of 38.4% in 2025. The market growth is driven by increasing demand for biologics and biosimilars, growing adoption of cell-based assays and advanced cell lines in drug discovery, rising outsourcing of cell line development to specialized service providers, and advancements in gene editing, high-throughput screening, and automated cell line development technologies.
Global Cell Line Development Services Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell line development services market report based on the service, source, application, end use, and region